Patent · US Active

Compositions and methods for modulating vascular development

US8790646B2 · kind B2 · utility

0Cited by
53References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 14, 2010
Grant dateJul 29, 2014
Priority date
Expiry dateOct 14, 2030

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2039/505
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides methods of using EGFL7 antagonist to modulate vascular development. Also provided herein are methods of screening for modulators of EGFL7 activity. Furthermore, methods of treatment using EGFL7 antagonists are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.